chrisvoncsefalvay/vaers-outcomes huggingface dataset:
DTaP given IM to R thigh on 11/20/02. Child's mom noticed on 11/21/02 the R thigh was slightly swollen and erythematous. On 11/22/02 upon awakening mom found the R thigh to be very swollen, tight and red around the injection site. The child was brought back to our clinic in no distress, playing, happy, afebrile. Was given a Rx for Orapred 15/5 1tsp bid x5 days and will f/u here on 11/25/02.
Narrative:  75 year old male who presented to ED on 12/30/21 with complaints of SOB, cough, chills, and fatigue. PMH includes COPD (pt on 4 L oxygen at baseline), arrhythmia, and DM. Tested positive for COVID-19 and was admitted for treatment. Treated with remdesivir and dexamethasoone and discharged on 1/1/22 with no new medications for home use. Presented back to ED on 1/4/22 for complaints of new and increasing SOB and O2 in mid 70s on 4L O2. Treated with dexamethasone again. Discharged on 1/7/22 back on baseline supplemental oxygen needs and home dexamethasone.
Strong Fatigue. Chills in fingers and toes, headache in back of neck, muscle pain in arms and shoulder, soreness at injection site, slight vision impairment lasting 24 hours
achy; tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achy) and FATIGUE (tired) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On an unknown date, the patient experienced PAIN (achy) and FATIGUE (tired). At the time of the report, PAIN (achy) and FATIGUE (tired) outcome was unknown.            Reporter did not allow further contact
9/21 burning in neck that went on for 2 days with itching 10/1 neck area burning that moved into shoulder up behind ear and behind left eye 10/2 occasionally hurts at cheekbone
can hardly walk or do anything; can hardly walk or do anything; light seems to be bothering; nausea; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (can hardly walk or do anything), ASTHENIA (can hardly walk or do anything), PHOTOPHOBIA (light seems to be bothering) and NAUSEA (nausea) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced GAIT DISTURBANCE (can hardly walk or do anything), ASTHENIA (can hardly walk or do anything), PHOTOPHOBIA (light seems to be bothering) and NAUSEA (nausea). At the time of the report, GAIT DISTURBANCE (can hardly walk or do anything), ASTHENIA (can hardly walk or do anything), PHOTOPHOBIA (light seems to be bothering) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were reported. For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessments.
This is a spontaneous report from a contactable consumer who reported for herself. This 72-year-old female consumer received PREVNAR 1) intramuscular, in left arm, in Oct2016, at single dose, for immunisation. Medical history and concomitant medications were not reported. Shortly after vaccination the consumer could not lift both arms on an unspecified date in 2016 with outcome of recovering, experienced muscle pain in both her arms and shoulders on an unspecified date in 2016 with outcome of not recovered, joint pain everywhere on an unspecified date in 2016 with outcome of not recovered, rash on the back of her neck on an unspecified date in 2016 with outcome of recovering, bad headaches on an unspecified date in 2016 with outcome of not recovered, she was dizzy in Dec2016 with outcome of not recovered, got the flu on an unspecified date in 2016 with outcome of resolved after 2 weeks, she could not even sleep on her sides because of the joint pain on an unspecified date in 2016 with unknown outcome.
Sat., chills began; Woke middle of the night with pain in Kidneys Fri a.m., pain got worse after 12 a.m.; Finding it impossible to sleep in bed or really rest; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ew0164) via an unspecified route of administration in the left arm on 21Apr2021 at 10:30 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. The medical history included diabetes type II. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included metformin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN) and pioglitazone (MANUFACTURER UNKNOWN), all from unknown dates and for unknown indications. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ep6955) via an unspecified route of administration in the left arm on 31Mar2021 at 10:15 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 02:45, the patient woke in middle of the night with pain in kidneys and found it impossible to sleep in bed or really rest. On 24Apr2021 after 00:00, the pain got worse and chills began. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain in kidneys, pain got worse, chills and finding it impossible to sleep in bed or really rest were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a physician assistant refers to a female patient of unknown age. On an unknown date the patient was vaccinated with a dose of GARDASIL with unknown strength, dose, route and lot number. The physician assistant reported an unspecified patient (the daughter of a friend) experienced a seizure after receiving GARDASIL. It was unknown if the patient sought medical attention. At the time of reporting, the outcome of event was not reported. Upon internal review, seizure was determined to be an other important medical event. Additional information has been requested.
Information has been received from a physician concerning a pt who was vaccinated with a dose of MMR II. The reporter "heard" that the pt "may have had a serious adverse event" and requested information regarding MMR II, encephalitis and coma. Unspecified medical attention was sought; however, the reporting physician noted that the pt was "not his pt." The reporter considered the adverse event to be an other important medical event. Additional info has been requested. Follow-up info was received on 06/27/02. The physician revealed that he is acting as a consutant on a legal case concerning this pt. He reported that she went on to develop encephalitis and later died. The reporter considered the encehalitis to be an other important medical event. Additional info has been requested.
Called for physician response to covid vaccine reaction. The following signs/symptoms were observed: itching   Heart Rate: 92, 90 BP: 147/91, 138/87   Treatment administered:   zyrtec 10 ml SL at 18:45   Response to treatment: Itching improved within a few minutes Disposition : discharge to home at 19:09 - instructed to return to ED / call 911 if worsening of symptoms
No adverse harm - had to give patient 1 extra poke to administer Hib separately as did not mix Pentacel correctly.  Only Dtap/IPV portion of pentacel given, and Hib given as Pedvax Hib.
Nausea. Vomiting.   Joint swelling  muscle     Couldn?t walk day 2.       Skin hurts.   Spine hurts.    Neck can?t band or turn.
I have had the two course vaccine in January and February 2021. I had the booster shot in December 2021 (all three moderna). I had normal reactions to each shot, including fever, headache, and body aches for several days.   What I still have are the worst and heaviest periods of my lif that started since I completed the first two vaccine doses. There is a significant difference in my cycle pre and post vaccination. I pass multiple, gigantic blood clots each cycle for days that can range from the size of a silver dollar to the entire size of my palm. In addition to clots, I go through more pads than ever and bleed significantly more. It feels like a flood. This all started post vaccination and it hasn?t subsided.  Im frustrated at how debilitating it is, how much work I miss, and how sick I get as a result of this each month.
Fever (100.3); Chills; Muscle aches; Nausea; Exhaustion; Administration date 09Oct2021, dose number=3; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 30135BA) via an unspecified route of administration in the right arm on 09Oct2021 at 10:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome (IBS) and kidney stones. The patient was sensitive to peanuts, nuts, milk and gluten, but was not an allergic. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198) via an unspecified route of administration in the right arm on 28Feb2021 at 13:45 (at the age of 51-years-old) as a single dose for COVID-19 immunisation and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via an unspecified route of administration in the right arm on 21Mar2021 at 13:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. On 09Oct2021 at 10:00, the patient had "administration date 09Oct2021, dose number=3". On 10Oct2021 at 09:00, the patient experienced fever (100.3), chills, muscle aches, nausea and exhaustion. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the of the events fever (100.3), chills, muscle aches, nausea and exhaustion. On 10Oct2021 at 09:00, the patient underwent body temperature test and the result was 100.3 (units were unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever (100.3), chills, muscle aches, nausea and exhaustion was not resolved. The clinical outcome of the event "administration date 09Oct2021, dose number=3" was unknown at the time of this report.
Lt arm hot, red and swollen after flu shot. Took Motrin, applied moist compress - arm is fine on 10/31/2002
Patient given Gardasil9 vaccine. Patient reported feeling and doing fine to medical staff, and appeared fine during reception checkout. Patient then experienced a vasovagal response in their personal vehicle (with mom present). Mom and/or patient reported that she lost her vision. Mom proceeded to call EMS from her personal vehicle in our parking lot. Patient was alert and talking to medical staff from our facility, as well as texting on her phone, prior to EMS response team arriving. Response team evaluated the patient and were done and leaving within 5 minutes of arriving. Patient and mom left momentarily afterward.
Fever began 8/14/03 (103 degrees). Leg hot and hard (swollen). Pt does not seem to be bothered by leg. Pt well oriented and talkative, not ill looking. Give Motrin 2 1/4 tsp or Tylenol 2 tsp. Reaction to DTaP. Came in 8/15/03. Came in for follow up on 8/18/03. Fever down to 99.9. Child says she eats OK and feels fine. Exam negative. Will have CBC with diff. if fever up to 103 degrees again.
Started with hives on chest, after a few minutes hives and welts started to appear on face, neck, chest, and arms.
I had a scratchy throat and started to lose my voice. Took a home COVID-19 test and it was positive. Called telehealth provider and was prescribed PAXLOVID. Tested again after 7 days and tested negative.
in less than 5 minutes following vaccine administration patient was reporting a feeling of something bad happening. She reported that her heart was going quickly and she was breathing fast. She then reported "funny feeling in my tongue." She was taken to an exam room immediately. She denied feeling of difficulty swallowing, tongue swelling, or trouble breathing. Vital signs pulse 120, blood pressure 190/90 while laying on exam table. Lungs clear without wheezing and pulse rapid but regular without murmur. Due to symptoms she was administered a dose of 0.3 mg of epinephrine via epi-pen in lateral left thigh. Patient not reporting difficulty swallowing and subsequently administered 10 mg cetirizine. Following epinephrine.
Couldn't sleep.; Couldn't walk.; severe pain in his right hip; This case was reported by a consumer via call center representative and described the occurrence of sleeplessness in a 70-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th June 2021, the patient received the 1st dose of Shingrix (intramuscular). On 9th June 2021, 2 hrs after receiving Shingrix, the patient experienced sleeplessness, unable to walk and pain in hip. On 10th June 2021, the outcome of the unable to walk was recovered/resolved. On an unknown date, the outcome of the sleeplessness was unknown and the outcome of the pain in hip was not recovered/not resolved.   It was unknown if the reporter considered the sleeplessness, unable to walk and pain in hip to be related to Shingrix.  Additional details was reported as follows: The age at vaccination was not reported. The patient received Shingrix and couldn't sleep, couldn't walk, and had severe pain in his right hip. The reporter was given medical disclaimer and was referred to Health care professional. The reporter consented to follow up.
NauseaVomiting  Narrative:  Side Effects:  1st: sore arm at injection site, later nausea/vomiting, feeling run down with general malaise for 2 days. 2rd: feverish, felt totally wiped out
Migraines began 6 days after administration and have not stopped since (current date 6/21/2022). Debilitating head pain,  nausea, dizziness, blurred vision, extreme light sensitivity, fatigue, depression, anxiety, hypersomnia, elevated blood pressures, myalgias, palpitations. MRI negative. Has seen a neurologist without symptom relief. Medications tried: rizatriptan, naratriptan,  indomethacin, ibuprofen, tylenol, fiorcet, propanolol, methylprednisone, amitriptyline, botox injections, ajovy.
Breakthrough case admission after 3 vaccines  Pfizer 1/14/21 lot# EL3249;  Pfizer 2/4/21 lot# EM9810;  Pfizer 12/2/21 lot# FH8027
The patient passed out on the sidewalk roughly 3.5-4 hr. after receiving the vaccine. The patient jogged to and from the vaccination site as a mode of transportation.
Painful lump in armpit, started a second period the day after the shot, fever, migraine, chest pains,severe back pain, pains in legs, light headedness
This case was reported by a healthcare professional and described the occurrence of hive-like rash over the body in a 6-month-old male subject who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis adsorbed, HEPATITIS B RECOMBINANT and (PEDIARIX, GlaxoSmithKline), rotavirus vaccine (MERCK) for prophylaxis. There were no concurrent medications. On 22 September 2008 at 10:00 the subject received 3rd dose of PEDIARIX at 0.5 ml in the left thigh and 3rd dose of ROTAVIRUS vaccine (MERCK). On 23 September 2008, 1 day after vaccination with PEDIARIX, at an unspecified time after vaccination with ROTAVIRUS vaccine, the subject experienced hive-like rash all over the body. At the time of reporting the event was improved but not completely resolved. The healthcare professional considered the event was probably related to vaccination with PEDIARIX.
No patients experienced any adverse effects; Improperly stored dose of ROTATEQ; This spontaneous report was received from a physician concerning a patient of unknown age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medications, or drug reactions/allergies.     On 17-APR-2020, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) vial (product storage error), by oral route (lot # 1660693, has been verified to be a valid lot number; expiration date 19-MAR-2021) as prophylaxis (dosage schedule and strength were not reported).   The administered dose of the vaccine experienced a multiple temperature excursions below highest temperature above 47 Fahrenheit degrees  to 66.6 Fahrenheit degrees for 2 hours and lowest temperature below 36 Fahrenheit degrees to 33.6 Fahrenheit degrees  for 45 minutes as recorded by a data logger. There was no previous temperature excursion. There was no adverse effect reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2006USA001703:
Pt recv vax & exp h/a,pain in back of neck & pressure sensation on top of the head. 4 days p/vax, pt devel weakness in legs w/waves of nausea. SEE comments
This spontaneous report was received from medical assistant refers to an unspecified patient of an unknown age and gender. The patient's relevant medical history, concurrent condition and concomitant medication were not reported. On 14-MAR-2016, patient was inadvertently administered with ROTATEQ suspension 2, that had been improperly stored, lot # L037921 (expiry date: 31-MAY-2017), orally (dosage not reported). The vaccine was stored at a temperature 30.2F and time frame: cumulative time of 132 hours. No previous temperature excursion was reported. No adverse effects reported. No product quality complaint (PQC) involved. No further information provided. This is one of several reports received from the same reporter. Additional information has been requested.
Chills; Muscle pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and MYALGIA (Muscle pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills) and MYALGIA (Muscle pain). At the time of the report, CHILLS (Chills) and MYALGIA (Muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Patient received 4 vaccines, reports no AEFI immediately after.  At day 12 after vaccination, patient reports subjective fever, myalgias, a 5x7cm red area around VAR injection site with 5/10 pain, and a maculopapular rash (2 papules on lower back, 1 on neck). Patient also reports "bumps" on her scalp but unable to find on PE.
patient received an expired Bexsero vaccine; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 17-year-old male patient who received Men B NVS (Bexsero) (batch number ABXB59AA, expiry date 30th September 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 12th October 2022, the patient received the 2nd dose of Bexsero and Bexsero Pre-Filled Syringe Device. On 12th October 2022, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 13-Oct-2022 Reporter's comment: The medical assistant called on 13th October 2022 and reported that yesterday on 12th October 2022 the patient received an expired Bexsero vaccine.  The health-care professional reported that this was 2nd dose.  The vaccine administration facility was the same as primary reporter. The consent to follow-up was granted via email. Additional Supportive Information: The patient was administrated with an expired dose of Bexsero, which led to expired vaccine used.
This spontaneous case reported by a consumer (subsequently medically confirmed), describes the occurrence of dyspnea (shortness of breath), cough, pyrexia (fever), headache and chills in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 037A21B) for COVID-19 immunization. The occurrence of additional events detailed below. Concurrent medical conditions included Hashimoto's disease. On Apr 9, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 10, 2021, patient myalgia (muscle aches). The patient treated with albuterol (salbutamol) for cough and shortness of breath, at an unspecified dose and frequency. On Apr 18, 2021, dyspnea (shortness of breath), cough, pyrexia (fever), headache, chills and myalgia (muscle aches) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medications reported. Lab data included COVID-19 test, flu test and X- ray (in emergency room) with unknown results. Description: The symptoms not related to COVID.
Dizziness ABD PAIN Narrative: ARM PAIN DAY 2 AND 3 FATIGUE AND ELEVATED BP DAY 2 AND 3 DAY 4 RESOLVED